NASDAQ:PXMD - Nasdaq - US70424C2035 - Common Stock - Currency: USD
PaxMedica (OTC: PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, has entered into definitive agreements for the immediate exercise of certain outstanding warrants. The agreements outline the “purchase up to an aggregate of 4,423,080 shares of common stock of the originally issued in November 2023, having an exercise price of 1.30 […]
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) (OTC:PXMD), a biopharmaceutical company...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips PaxMedica (NASDAQ:PXMD) just reported results for the first quarter of 2024.Pax...
PXMD stock results show that PaxMedica missed analyst estimates for earnings per share the first quarter of 2024.
Motus GI stock is falling hard on Friday following a delisting notice for MOTS shares that the company doesn't intend to appeal.
TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading biopharmaceutical company...
Allarity Therapeutics stock is up on Monday alongside heavy trading of ALLR shares on a prospectus update from the company.
Mentions: ALLR
PaxMedica stock is up on Friday with heavy trading of PXMD after announcing a new key milestone in PAX-101 drug development.
Emergent shortages of the drug used to treat the most severe form of African sleeping sickness creates immediate need for direct access to the global drug...
Applied Digital stock fell on Friday as APLD investors react to the company missing EPS and revenue estimates in fiscal Q3 2024.
Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!
TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing...
TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing...